Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 7,355 shares at $50.16 ($369K) on 2020-09-16, disclosed to the SEC on 2020-09-16.
Open-market sale of $369k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 111 | $6K | 1.5% |
| 2 | $50.06 | 1,000 | $50K | 13.6% |
| 3 | $50.16 | 3,122 | $157K | 42.5% |
| 4 | $50.16 | 3,122 | $157K | 42.5% |
| Total | $50.14 avg | 7,355 | $369K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |
| EIDX | SELL | 2020-06-05 | $250K | — | Filing → |